SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subtypes, which have differences in prognosis and sens...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Madera, Santiago, Chiauzzi, Violeta A, Chervo, María F, Pereyra, Matías G, Venturutti, Leandro, Deamicis, Agustina Roldán, Dupont, Agustina, Guzmán, Pablo, Roa, Juan C, Cenciarini, Mauro E, Barchuk, Sabrina, Figurelli, Silvina, Vecchia, Daniel Lopez Della, Ares, Sandra, Proietti, Cecilia J, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia V, Cordo Russo, Rosalia I
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Tumor Biology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares